Drug Search Results
More Filters [+]

Tilorone

Alternative Names: tilorone
Latest Update: 2023-10-19
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: RIG1 Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Russia | Ukraine

Approved Indications: None

Known Adverse Events: None

Company: Institute of Occupational Hygiene and Poison Control, Chinese Center for Disease Control and Prevention/Beijing Zhongcheng Jianxin Investment Services Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tilorone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Silicosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20221121

P1

Completed

Silicosis

2006-12-31

CTR20221117

P1

Completed

Silicosis

2006-12-31

Recent News Events